Pulmonary embolism: Pathophysiology, diagnosis, treatment

Hellenic Journal of Cardiology

Volumn 48, Issue 2, 2007, Pages 94-107

  Kostadima, Eleni ^a   Zakynthinos, Epaminondas ^a,b  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b NONE   (Greece)

Author keywords

Anticoagulant therapy; Computed tomography; D dimers; Embolectomy; Pulmonary embolism risk factors; Thrombolysis

Indexed keywords

ADRENALIN; ALTEPLASE; DOBUTAMINE; DOPAMINE; HEPARIN; ISOPRENALINE; NORADRENALIN; ANTICOAGULANT AGENT;

BLOOD CLOT LYSIS; CARBON DIOXIDE TENSION; DEEP VEIN THROMBOSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; EMBOLECTOMY; HUMAN; INCIDENCE; LUNG CIRCULATION; LUNG EMBOLISM; MORTALITY; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; THROMBECTOMY; THROMBOEMBOLISM; FIBRINOLYTIC THERAPY; LUNG GAS EXCHANGE; VENA CAVA FILTER;

ANTICOAGULANTS; EMBOLECTOMY; HUMANS; PULMONARY CIRCULATION; PULMONARY EMBOLISM; PULMONARY GAS EXCHANGE; RISK FACTORS; THROMBOLYTIC THERAPY; VENA CAVA FILTERS;

EID: 34548067167     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Goldhaber SZ, Visani L, De Rosa M: Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389.
2. Moser KM, Fedullo PF, LitteJohn JK, et al: Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994; 271: 223-225.
3. Smulders YM: Contribution of pulmonary vasoconstriction to hemodynamic instability after acute pulmonary embolism. Implications for treatment? Neth J Med 2001; 58: 241-247.
4. Bobadilla RA, Garcia-Juarez JA, Hong E, et al: Serotonergic receptors involved in the hemodynamic changes observed during pulmonary embolism. Proc West Pharmacol Soc 1991; 34: 439-442.
5. Schmidt GA: Pulmonic embolic disorders: Thrombus, Air and Fat, in Hall JB, Schmidt GA, Wood LDH (eds): Principles of Critical Care. McGraw-Hill 1992; pp 1476-1492.
6. Crapo RO, Jensen RL, Wanger JS: Single-breath carbon monoxide diffusing capacity. Clin Chest Med 2001; 22: 637-649.
7. Elliott CG: Pulmonary physiology during pulmonary embolism. Chest 1992; 101(Suppl): 163S-171S.
8. Itti E, Nguyen S, Robin F, et al: Distribution of ventilation/perfusion ratios in pulmonary embolism: an adjunct to the interpretation of ventilation/perfusion lung scans. J Nucl Med 2002; 43: 1596-1602.
9. Wood KE: Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121: 877-905.
10. Belenkie I, Dani R, Smith ER, et al: Ventricular interaction during experimental acute pulmonary embolism. Circulation 1988; 78: 761-768.
11. Goldhaber SZ: Echocardiography in the management of pulmonary embolism. Ann Intern Med 2002; 136: 691-700.
12. Anderson FA Jr, Spencer FA: Risk factors for venous thromboembolism. Circulation 2003; 107: 109-116.
13. Lapostolle F, Surget V, Borron SW, et al: Severe pulmonary embolism associated with air travel. N Engl J Med 2001; 345: 779-783.
14. Goldhaber SZ, Grodstein F, Stampfer MJ, et al: A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277: 642-645.
15. Rosing J, Middeldorp S, Curvers J, et al: Low dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Lancet 1999; 354: 2036-2040.
16. Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al: Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001; 344: 1527-1535.
17. Parkin L, Skegg DC, Wilson M, et al: Oral contraceptives and fatal pulmonary embolism. Lancet 2000; 355: 2133-2134.
18. Greer IA: Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353: 1258-1265.
19. Nelson HD, Humphrey LL, Nygren P, et al: Postmenopausal hormone replacement therapy: scientific review. JAMA 2002; 288: 872-881.
20. Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
21. Cummings SR, Eckert S, Krueger KA, et al: The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. JAMA 1999; 281: 2189-2197.
22. Cuzick J, Forbes J, Edwards R, et al: First results from the International Breast Cancer Intervention Study (IBIS-I): a randomized prevention trial. Lancet 2003; 360: 817-824.
23. Schulman S, Lindmarker P: Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism: Duration of Anticoagulation Trial. N Engl J Med 2000; 342: 1953-1958.
24. Sorensen HT, Mellemkjaer L, Olsen JH, et al: Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343: 1846-1850.
25. Prandoni P, Lensing AW, Buller HR, et al: Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-1133.
26. Huber O, Bounameaux H, Borst F, et al: Postoperative pulmonary embolism after hospital discharge: an underestimated risk. Arch Surg 1992; 127: 310-313.
27. Hyers TH: Venous thromboembolism. Am J Respir Crit Care Med 1999; 159: 1-14.
28. Bertina RM, Koeleman BPC, Koster T, et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
29. Price DT, Ridker PM: Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997; 127: 895-903.
30. Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, et al: Enhancement by factor V Leiden mutation of risk of deepvein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593-1596.
31. Ryan DH, Crowther MA, Ginsberg JS, et al: Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement therapy. Ann Intern Med 1998; 128: 270-276.
32. Zakynthinos E, Pantazopoulos K: Acute mechanical mitral valve thrombosis early after neurosurgery: is factor V Leiden mutation contributing? Int J Cardiol 2004; 96: 487-488.
33. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.
34. Hankey GJ, Eikelboom JW: Homocysteine and vascular disease. Lancet 1999; 354: 752-763.
35. Goldhaber SZ: Pulmonary embolism. N Engl J Med 1998; 339: 93-104.
36. Stein PD, Terrin ML, Hales CA, et al: Clinical, laboratory, roentgenographic and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991; 100: 598-603.
37. Hirsh J, Hoak J: Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 1996; 93: 2212-2245.
38. Stein PD, Goldhaber SZ, Henry JW, et al: Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest 1996; 109: 78-81.
39. Miniati M, Prediletto R, Formichi B, et al: Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 1999; 159: 864-871.
40. Palla A, Petruzzelli S, Donnamaria V, et al: The role of suspicion in the diagnosis of pulmonary embolism. Chest 1995; 107: 21-24.
41. Ferrari E, Baudouy M, Cerboni P, et al: Clinical epidemiology of venous thrombo-embolic disease. Results of a French multicentre registry. Eur Heart J 1997; 18: 685-691.
42. Wells PS, Anderson DR, Rodger M, et al: Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the model's utility with the SimpliRED D-dimer. Thrombosis and Haemostasis 2000; 83: 416-420.
43. Ferrari E, Imbert A, Chevalier T, et al: The ECG in pulmonary embolism: predictive value of negative T waves in precordial leads - 80 case reports. Chest 1997; 111: 537-543.
44. Daniel KR, Courtney DM, Kline JA: Assessment of cardiac stress from massive pulmonary embolism with 12-lead ECG. Chest 2001; 120: 474-481.
45. Pistolesti M, Miniati M: Imaging techniques in treatment algorithms of pulmonary embolism. Eur Respir J 2002; 19: 28-39.
46. Goldhaber SZ, Dricker E, Buring JE, et al: Clinical suspicion of autopsy-proven thrombotic and tumor pulmonary embolism in cancer patients. Am Heart J 1987; 114: 1432-1435.
47. Kelly J, Hunt BJ: Role of D-dimers in diagnosis of venous thromboembolism. Lancet 2002; 359: 456-458.
48. Wells PS, Anderson DR, Rodger M, et al: Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 2001; 135: 98-107.
49. Konstantinides S, Geibel A, Olschewski M, et al: Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106: 1263-1268.
50. Kucher N, Printzen G, Doernhoefer T, et al: Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation 2003; 107: 1576-1578.
51. Wolde M, Tulevski II, Mulder JW, et al: Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 2003; 107: 2082-2084.
52. Kucher N, Printzen G, Goldhaber SZ: Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107: 2545-2556.
53. A Collaborative Study by the PIOPED Investigators: Value of the ventilation/perfusion scan in acute pulmonary embolism-results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 2753-2759.
54. Bone RC: The low-probability lung scan: a potentially lethal reading. Arch Intern Med 1993; 153: 2621-2622.
55. Perrier A, Howarth N, Didier D, et al: Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med 2001; 135: 88-97.
56. Stein PD, Fowler SE, Goodman LR, et al: PIOPED II Investigators: Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006; 354: 2317-2327.
57. Perrier A, Roy PM, Sanchez O, et al: Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med 2005; 352: 1760-1768.
58. Oudkerk M, van Beek EJ, Wielopolski P, et al: Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002; 359: 1643-1647.
59. Meaney JFM, Weg JG, Chenevert TL, et al: Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 1997; 336: 1422-1427.
60. Kasper W, Geibel A, Tiede N, et al: Distinguishing between acute and subacute massive pulmonary embolism by conventional and Doppler echocardiography. Br Heart J 1993; 70: 352.
61. Jardin F, Dubourg O, Bourdarias JP: Echocardiographic pattern of acute cor pulmonale. Chest 1997; 111: 219-1217.
62. McConnell MV, Solomon SD, Rayan ME, et al: Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996; 78: 469-473.
63. Zakynthinos E, Zakynthinos S: Contemporary diagnosis and therapy of pulmonary hypertension. Hellenic J Cardiol 1991; 32: 111-123.
64. Miniati M, Monti S, Pratali L, et al: Value of transthoracic echocardiography in the diagnosis of pulmonary embolism: results of a prospective study in unselected patients. Am J Med 2001; 110: 528-535.
65. Pruszczyk P, Torbicki A, Pacho R, et al: Noninvasive diagnosis of suspected severe pulmonary embolism. Transesophageal echocardiography vs spiral CT. Chest 1997; 112: 722-728.
66. Zakynthinos E, Douka E, Daniil Z, Konstantinidis K, Markaki V, Zakynthinos S: Anuria due to acute bilateral renal vein occlusion after thrombolysis for pulmonary embolism. Int J Cardiol 2005; 101: 163-166.
67. Stein PD, Athanasoulis C, Alavi A, et al: Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 1992; 85: 462-468.
68. Permlutt LM, Braun SD, Newman GE, et al: Pulmonary angiography in the high-risk patient. Radiology 1987; 162: 187.
69. Fraser J, Anderson R: Venous protocols, techniques, and interpretation of the upper and lower extremities. Radiol Clin N Am 2004; 42: 279-296.
70. Kearon C, Julian JA, Newman TE, et al: Noninvasive diagnosis of deep venous thrombosis: McMaster diagnostic imaging practice guidelines initiative. Ann Intern Med 1998; 128: 663-671.
71. Rose SC, Zwiebel WJ, Nelson BD, et al: Symptomatic lower extremity deep venous thrombosis: accuracy limitations and role of color duplex flow imaging in diagnosis. Radiology 1990; 175: 639-644.
72. Wells PS, Hirsh J, Anderson DR, et al: Comparison of the accuracy of impedance plethysmography and compression ultrasonography in outpatients with clinically suspected deep venous thrombosis: a two centre paired-design clinical trial. Thromb Haemost 1995; 74: 1423-1427.
73. Heijboer H, Buller HR, Lensing AWA, et al: A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med 1993; 329: 1365-1369.
74. Pedersen OM, Aslaksen MA, Vik-Mo A, et al: Compression ultrasonography in hospitalized patients with suspected deep venous thrombosis. Arch Intern Med 1991; 151: 2217-2220.
75. Davidson BL, Elliott CG, Lensing AWA, for the RD Heparin Arthroplasty Group: Low accuracy of color Doppler ultrasound in the detection of proximal leg thrombosis in asymptomatic high-risk patients. Ann Intern Med 1992; 117: 735-738.
76. Carpenter JP, Holland GA, Baum RA, et al: Magnetic resonance venography for the detection of deep venous thrombosis: comparison with contrast venography and duplex Doppler ultrasonography. J Vasc Surg 1993; 18: 734-744.
77. Kearon C: Excluding pulmonary embolism with helical (spiral) computed tomography: evidence is catching up with enthusiasm. CMAJ 2003; 168: 1430-1431.
78. van Strijen MJ, de Monye W, Schiereck J, et al: Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients. Ann Intern Med 2003; 138: 307-714.
79. Musset D, Parent F, Meyer G, et al: Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet 2002; 360: 1914-1920.
80. Samama MM: Treatment of deep vein thrombosis and pulmonary embolism. Archives of Hellenic Medicine 2000; 17: 75-77.
81. Mirianthefs M, Zampartas K: Pulmonary embolism - Case report. Advances in treatment. Cyprus Medicine 1994; 12: 24-29.
82. Kouraklis G: Pulmonary embolism as a clinical problem; its treatment. Iatriki 1987; 52: 395-404.
83. Molloy WD, Lee KY, Girling L, et al: Treatment of shock in a canine model of pulmonary embolism. Am Rev Respir Dis 1984; 130: 870.
84. Belenkie I, Dani R, Smith ER, et al: Effects of volume loading during experimental acute pulmonary embolism. Circulation 1989; 80: 178.
85. Tsapogas M: Contemporary aspects in vein thrombosis. Hellenic Surgery 1987; 59: 411-418.
86. Cruickshank MK, Levine MN, Hirsh J, et al: A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 1991; 151: 333.
87. Raschke RA, Reilly BM, Guidry JR, et al: The weight-based heparin dosing nomogram compared with a "standard care" nomogram: A randomized controlled trial. Ann Intern Med 1993; 119: 874-881.
88. Levine MN, Hirsh J, Gent M, et al: A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 1994; 154: 49-56.
89. Pearson SD, Lee TH, McCabe-Hassan S, et al: A critical pathway to treat proximal lower extremity deep vein thrombosis. Am J Med 1996; 100: 283.
90. Schulman S, Rhedin A-S, Lindmarker P, et al: A comparison of 6 weeks with 6 months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661-1665.
91. Schulman S, Granqvist S, Holmstrom M, et al: The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997; 336: 393-398.
92. Van den Belt AGM, Sanson B-J, Simioni P, et al: Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Intern Med 1997; 157: 2227-2232.
93. Hirsh J, Kearon C, Ginsberg J: Duration of oral anticoagulant therapy after first episode of venous thromboembolism in patients with inherited thrombophilia. Arch Intern Med 1997; 157: 2174-2177.
94. The Columbus Investigators: Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657-662.
95. Simonneau G, Sors H, Charbonnier B, et al: A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663-669.
96. Pacouret G, Alison D, Pottier J-M, et al: Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis: a prospective study. Arch Intern Med 1997; 157: 305-308.
97. Decousus H, Leizorovicz A, Parent F, et al: A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998; 338: 409-415.
98. Wan S, Quinlan DJ, Agnelli G, et al: Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 2004; 110: 744-749.
99. Jerjes-Sanchez C, Ramirez-Rivera A, Garcia ML, et al: Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis 1995; 2: 227-229.
100. Arcasoy SM, Kreit JW: Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest 1999; 115: 1695-1707.
101. Goldhaber SZ, Haire WD, Feldstein ML, et al: Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-511.
102. Buller HR, Agnelli G, Hull RD, et al: Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(Suppl 3): 401-428.
103. Goldhaber SZ: Thrombolysis for pulmonary embolism. N Engl J Med 2002; 347: 1131-1132.
104. Konstantinides S: Should thrombolytic therapy be used in patients with pulmonary embolism? Am J Cardiovasc Drugs 2004; 4: 69-74.
105. Dong B, Jirong Y, Liu G, et al: Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev 2006; 19: CD004437.
106. Dalen JE: Thrombolysis in submassive pulmonary embolism? No. J Thromb Haemost 2003; 1: 1130-1132.
107. Goldhaber SZ: Thrombolysis in submassive pulmonary embolism. J Thromb Haemost 2004; 2: 1473-1474.
108. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W; Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators: Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-1150.
109. Konstantinides S: Thrombolysis in submassive pulmonary embolism? Yes. J Thromb Haemost 2003; 1: 1127-1129.
110. Konstantinides S: Diagnosis and therapy of pulmonary embolism. Vasa 2006; 35: 135-146.
111. Daniels LB, Parker JA, Patel SR, et al: Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol 1997; 80: 184-188.
112. Meyer G, Koning R, Sors H: Transvenous catheter embolectomy. Semin Vasc Med 2001; 1: 247-252.
113. Aklog L, Williams CS, Byrne JG, et al: Acute pulmonary embolectomy: a contemporary approach. Circulation 2002; 105: 1416-1419.
114. Koning R, Cribier A, Gerber L, et al: A new treatment for severe pulmonary embolism: percutaneous rheolytic thrombectomy. Circulation 1997; 96: 2498-2500.
115. Gulba DC, Schmid C, Borst H-G, et al: Medical compared with surgical treatment for massive pulmonary embolism. Lancet 1994; 343: 576-577.
116. Meyer G, Tamisier D, Sors H, et al: Pulmonary embolectomy: a 20 year experience at one center. Ann Thorac Surg 1991; 51: 232-236.
117. Stulz P, Schlapfer R, Feer R, et al: Decision making in the surgical treatment of massive pulmonary embolism. Eur J Cardiothorac Surg 1994; 8: 188-193.
118. Hartz RS: Surgery for chronic thromboembolic pulmonary hypertension. World J Surg 1999; 23: 1137-1147.
119. Archibald CJ, Auger WR, Fedullo PF, et al: Long-term outcome after pulmonary thromboendartectomy. Am J Respir Crit Care Med 1999; 160: 523-528.
120. Jamieson S, Kapelanski D, Sakakibara N, et al: Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003; 76: 1457-1464.
121. Mellemkjaer S, Ilkjaer LB, Klaaborg KE, et al: Pulmonary endarterecomy for chronic thromboembolic pulmonary hypertension. Ten years experience in Denmark. Scand Cardiovasc J 2006; 40: 49-53.
122. Ogino H, Ando M, Matsuda H, et al: Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2006; 82: 630-636.
123. Pengo V, Lensing AW, Prins MH, et al: Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.